304 - Clinical-grade manufacturing of switchable CAR-T cells in an automated closed system for phase I/II trials

Autor: Dietrich, J., Riewaldt, J., Loff, S., Meyer, J., Schallenberg, S., Spehr, J., Gründer, C., Franke, K., Kreissig, C., Ehninger, G., Bachmann, M., Ehninger, A., Cartellieri, M.
Zdroj: In Cytotherapy May 2018 20(5) Supplement:S103-S104
Databáze: ScienceDirect